Skip to content

Clinical efficacy of electroacupuncture at different frequencies for acute-stage periarthritis of the shoulder (Hand-Shaoyang meridian type)

Observation on the Clinical Efficacy of Electroacupuncture at Different Frequencies in the Treatment of Acute Shoulder Periarthritis (Hand Shaoyang Meridian Type)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000862
Enrollment
Unknown
Registered
2026-04-02
Start date
2025-03-27
Completion date
Unknown
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute-stage periarthritis of the shoulder (Hand-Shaoyang meridian type)

Interventions

Low Frequency Group (2 Hz):Electroacupuncture (continuous wave, 2 Hz), intensity adjusted to participant tolerance, 30 min per session, with concurrent TDP heat irradiation to the shoulder. Acupoints:
5 consecutive days per course, 2-day interval between courses
2 courses in total.
High-frequency group (100 Hz):Electroacupuncture (continuous wave, 100 Hz), intensity adjusted to participant tolerance, 30 min per session, with concurrent TDP heat irradiation. All acupoints, needli
only the EA frequency differs. Once daily
5 days per course with a 2-day interval
2 courses total.

Sponsors

Affiliated Third Clinical Hospital of University of Chinese Medicine in Changchun
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Meets the diagnostic criteria for periarthritis of the shoulder (Frozen shoulder), including the classic Codman five signs/diagnostic points, and conforms to the TCM syndrome differentiation criteria for this study (Hand Shaoyang Meridian type/Leoshanfeng-related classification, as per the protocol/guidelines). (2) 40 = age = 80 years old, gender, unilateral onset, duration of illness <36 weeks; (3) No specific treatment for periarthritis of the shoulder has been received within 2 weeks of this onset (including but not limited to intra-articular injection therapy, nerve block therapy, surgical therapy, etc.); (4) Voluntarily signs the Informed Consent Form, agrees to participate in this study, and has no major health conditions (including but not limited to infections, coagulation disorders, heart disease, tumors, etc.); (5) Good compliance, able to adhere to the treatment.

Exclusion criteria

Exclusion criteria: (1) Those who do not meet the above diagnostic criteria and inclusion criteria; (2) Individuals with a history of severe shoulder trauma or surgery (including but not limited to fractures, dislocations, severe rotator cuff tear injuries, etc.); (3) Patients with shoulder pain and functional impairment caused by other primary diseases (including but not limited to rotator cuff injuries, subacromial impingement syndrome, cervicothoracic syndrome, bone tumors, shoulder tuberculosis, etc.); (4) Individuals who have participated in other clinical trials within the past month; (5) Patients with contraindications for acupuncture, such as rashes, skin breaks, or abscesses around the shoulder; individuals with coagulation disorders; patients with severe systemic diseases (e.g., heart, brain, or kidney); pregnant or breastfeeding patients; or patients with other infectious diseases; (6) Patients with severe mental disorders or intellectual disabilities who lack the ability to act independently and cannot cooperate with the treatment; (7) Patients who may withdraw from the study due to personal scheduling arrangements.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale (VAS);

Secondary

MeasureTime frame
Constant-Murley Score Shoulder Assessment (CMS);Activities of Daily Living (ADL) scale;Range of Motion (ROM);

Countries

China

Contacts

Public ContactShang Yi

Changchun University of Chinese Medicine

1846329041@qq.com18143698578

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Aug 29, 2026